The company will protect the branded anti-interleukin (IL)-12/23 biologic against sales erosion from pending biosimilars.

The Goldman Sachs Group, Inc. ( NYSE: GS) Q4 2024 Earnings Conference Call January 15, 2025 9:30 AM ET Ebrahim Poonawala - Bank of America Christian Bolu - Autonomous Research Betsy Graseck - Morgan ...

On indirect taxation, the Forum has advocated for a simplified customs tariff structure with three rates-0 per cent, 5 per ...

The plant is expected to unlock a revolutionary new avenue for the production and application of green hydrogen ...

U.S. stock exchanges. The HFRI EH FVI reflects fundamental value strategies which employ investment processes designed to ...

On the sidelines of the World Future Energy Summit (WFES) during Abu Dhabi Sustainability Week, BEEAH, has revealed ...

AdventHealth and Novant Health have set $30 billion annual revenue targets, fueled by a growing demand for care and interest ...

Tombstone Generator: Via FactSet screening or client-sourced transactions in Excel, junior bankers can quickly generate new tombstone slides for pitchbooks. Pitch Creator automates manual and ...

Q1 2025 Earnings Call Transcript January 10, 2025 WD-40 Company beats earnings expectations. Reported EPS is $1.39, ...

The possibility of President-elect Donald Trump’s administration imposing tariffs could lead to higher inflation in the United States, resulting in higher US interest rates and tighter monetary policy ...

The federal government has set a target of N6.58 trillion in revenue for the NCS in 2025, reflecting ambitious growth.

Destiny Media Technologies Inc. (PNK: DSNY) Q1 2025 Earnings Call Transcript January 14, 2025 ...